In other words, the SMN protein supplied from the mother to the foetus may suppress the development of SMA in the infant at birth, and depletion of the SMN protein may occur after birth, causing the infant to develop SMA. This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.